Join Now

Category Archives: BioUtah News

PolarityTE Secures $22.5 Million Financing to Advance SkinTE Phase III Pivotal Study in Diabetic Foot Ulcers

By Natalie Themm | Published May 23, 2024

PolarityTE Secures $22.5 Million Financing to Advance SkinTE Phase III Pivotal Study in Diabetic Foot Ulcers

| Tagged | Comments Off on PolarityTE Secures $22.5 Million Financing to Advance SkinTE Phase III Pivotal Study in Diabetic Foot Ulcers

Sorriso Pharmaceuticals Announces First Patients Dosed in Phase 1b Clinical Trial for Patients with Ulcerative Colitis

By Natalie Themm | Published May 23, 2024

Study to Evaluate SOR102, a Novel Oral Dual-Acting Antibody Targeting TNF⍺ and IL-23 (p19) for Inflammatory Bowel Disease

| Tagged | Comments Off on Sorriso Pharmaceuticals Announces First Patients Dosed in Phase 1b Clinical Trial for Patients with Ulcerative Colitis

EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections

By admin | Published May 16, 2024

Major Milestone for EVŌQ Nano’s Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung Diseases   SALT LAKE CITY, Utah, (May 15, 2024) — EVŌQ Bio, a wholly-owned subsidiary of EVŌQ Nano, today announced the successful completion of a Pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) […]

| Comments Off on EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections

Merit Medical Shareholders Elect Silvia M. Perez as New Director

By admin | Published May 16, 2024

Experienced healthcare veteran brings a broad background spanning clinical, regulatory, operations, marketing, and business leadership to Merit’s Board of Directors SOUTH JORDAN, Utah, May 16, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that its shareholders elected Silvia M. Perez, President of the Commercial Branding and […]

| Comments Off on Merit Medical Shareholders Elect Silvia M. Perez as New Director

EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections

By Natalie Themm | Published May 16, 2024

Major Milestone for EVŌQ Nano’s Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung Diseases

| Tagged | Comments Off on EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections

Halia Therapeutics to Unveil New Clinical Program Targeting the LRRK2 Protein for Alzheimer’s Disease at Discovery Europe 2024

By Natalie Themm | Published May 16, 2024

Dr. Bearss will be the Chair of the “Drug Discovery for Neurodegenerative Diseases” session, on May 23.

| Tagged | Comments Off on Halia Therapeutics to Unveil New Clinical Program Targeting the LRRK2 Protein for Alzheimer’s Disease at Discovery Europe 2024

Merit Medical Executive Leadership Team Update

By Natalie Themm | Published May 16, 2024

Joe Wright Appointed President, Expands Deep Bench of Leadership Team Talent; Supports “Continued Growth Initiatives” Program.

| Tagged | Comments Off on Merit Medical Executive Leadership Team Update

Merit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug and Bearing nsPVA Express™ Prefilled Syringe

By Natalie Themm | Published May 16, 2024

New products broaden Merit’s leadership in embolotherapy.

| Tagged | Comments Off on Merit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug and Bearing nsPVA Express™ Prefilled Syringe

Owlet Announces UK Medical Certification of Dream Sock®

By Natalie Themm | Published May 16, 2024

Parents in the United Kingdom will soon have access to Owlet’s Dream Sock with UKCA certification.

| Tagged | Comments Off on Owlet Announces UK Medical Certification of Dream Sock®

PhotoPharmics Enrolls First 25 Patients in Pivotal Parkinson’s Disease Study to Improve Symptoms Beyond the Current Standard of Care

By Natalie Themm | Published May 16, 2024

Groundbreaking at-home pivotal trial of a much-anticipated therapeutic device is underway.

| Tagged | Comments Off on PhotoPharmics Enrolls First 25 Patients in Pivotal Parkinson’s Disease Study to Improve Symptoms Beyond the Current Standard of Care

Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry

By Natalie Themm | Published May 16, 2024

BioHive-2, an NVIDIA DGX SuperPOD with NVIDIA DGX H100 systems, ranked #35 in the TOP500 list of the most powerful supercomputers in the world across all industries as of May 2024.

| Tagged | Comments Off on Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry

BioHive Live Recap

By admin | Published May 9, 2024

BioHive Live, BioHive’s inaugural industry-wide event with over 350 registrants took center stage at the Hale Center Theatre in Sandy, Utah on Wednesday. The event featured a series of thought-provoking speakers who engaged, inspired and challenged the audience. Jared Bauer, CEO of Seek Labs and BioHive board chair, welcomed attendees along with Aimee Edwards, BioHive […]

| Comments Off on BioHive Live Recap

A Special Thanks To Our Legacy and Platinum Elite Members